These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus]. Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V. Vnitr Lek; 1997 Oct 08; 43(10):639-44. PubMed ID: 9601876 [Abstract] [Full Text] [Related]
3. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)]. Hashimoto H, Utagawa Y, Yamagata J, Okada T, Shiokawa Y, Suzuki S, Tomiyama T. Ryumachi; 1981 Sep 08; 21(5):366-74. PubMed ID: 6977194 [No Abstract] [Full Text] [Related]
4. Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus. Ludivico CL, Zweiman B, Myers AR, Hebert J, Green PA. J Rheumatol; 1980 Sep 08; 7(6):843-9. PubMed ID: 6970815 [Abstract] [Full Text] [Related]
5. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus. Nguyen CP, Cao VV, Fehér J, Gergely P. Acta Med Hung; 1988 Sep 08; 45(2):145-59. PubMed ID: 3266790 [Abstract] [Full Text] [Related]
6. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus. Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M. Hum Immunol; 2006 Nov 08; 67(11):924-30. PubMed ID: 17145372 [Abstract] [Full Text] [Related]
7. [Laboratory and morphologic parameters in patients with lupus nephritis]. Rasković S, Bogić M, Perić-Popadić A, Stefanović L, Arandjelović S, Jovicić Z, Bolpacić J, Tomić-Spirić V. Srp Arh Celok Lek; 2002 Aug 08; 130 Suppl 3():38-41. PubMed ID: 12583312 [Abstract] [Full Text] [Related]
8. [Antibodies against soluble nuclear antigens of the SS-A or SS-B type. Significance in systemic lupus erythematosis (author's transl)]. Meyer O, Haim T. Nouv Presse Med; 1981 Jun 13; 10(26):2179-84. PubMed ID: 6973748 [Abstract] [Full Text] [Related]
9. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome]. Akiyama Y, Suzuki T, Tanaka M, Kobayashi K, Kagiri T, Ishibashi T, Kitagawa H, Imai F, Hara K, Doi Y. Arerugi; 1990 Jun 13; 39(6):542-7. PubMed ID: 2222196 [Abstract] [Full Text] [Related]
10. Autoimmunity and laboratory testing for systemic lupus erythematosus (SLE) and allied diseases. Deodhar SD. Lab Res Methods Biol Med; 1983 Jun 13; 8():89-100. PubMed ID: 6358749 [Abstract] [Full Text] [Related]
11. Antitopoisomerase I antibody in patients with systemic lupus erythematosus/sicca syndrome without a concomitant scleroderma: two case reports. Al Attia HM, D'Souza MS. Clin Rheumatol; 2003 Feb 13; 22(1):70-2. PubMed ID: 12605324 [Abstract] [Full Text] [Related]
12. [Clinico-immunological characteristics of systemic lupus erythematosus with Raynaud and Sjögren's syndromes (report I)]. Nasonova VA, Poverennyĭ AM, Nasonov EL, Lekakh IV, Tachmuradova MD. Ter Arkh; 1985 Feb 13; 57(5):94-8. PubMed ID: 3161200 [Abstract] [Full Text] [Related]
13. A syndrome of multiple immune autoreactivity. A breakdown in immune regulation. Diaz LA, Glamb RW, Silva J. Arch Dermatol; 1980 Jan 13; 116(1):77-9. PubMed ID: 6986118 [Abstract] [Full Text] [Related]
14. [The Ha(La) antibody as a serologic marker of systemic lupus erythematosus]. Lakomek HJ, Wagener S, Schwochau M, Krüskemper HL. Z Rheumatol; 1988 Jan 13; 47(2):86-92. PubMed ID: 3260430 [Abstract] [Full Text] [Related]
15. Useful laboratory measurements in the management of systemic lupus erythematosus. Morrow WJ, Isenberg DA, Todd-Pokropek A, Parry HF, Snaith ML. Q J Med; 1982 Jan 13; 51(202):125-38. PubMed ID: 6981121 [Abstract] [Full Text] [Related]
16. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases. Wells JV, Webb J, Van Deventer M, Fry B, Pollard KM, Raftos J, Monk W, Nelson DS. Clin Exp Immunol; 1979 Dec 13; 38(3):424-35. PubMed ID: 394890 [Abstract] [Full Text] [Related]
17. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ. J Immunol; 1985 Sep 13; 135(3):2005-14. PubMed ID: 4020137 [Abstract] [Full Text] [Related]
18. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis. Klein MH, Thorner PS, Yoon SJ, Poucell S, Baumal R. Int J Pediatr Nephrol; 1984 Jun 13; 5(2):75-82. PubMed ID: 6333404 [Abstract] [Full Text] [Related]
19. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease. Ichikawa Y, Takaya M, Shimizu H, Uchiyama M, Moriuchi J, Morita K, Hoshina Y, Horiki T. Tokai J Exp Clin Med; 1993 Dec 13; 18(3-6):133-8. PubMed ID: 7701526 [Abstract] [Full Text] [Related]
20. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus. Meryhew NL, Kimberly RP, Messner RP, Runquist OA. J Immunol; 1986 Jul 01; 137(1):97-102. PubMed ID: 3486919 [Abstract] [Full Text] [Related] Page: [Next] [New Search]